Annual report

VALBIOTIS publishes its 2018 annual report and announces its results.

Read the document

VALEDIA®

VALBIOTIS obtains the European patent for VALEDIA®.

Read the press release

VALEDIA®

A major scientific innovation for people with prediabetes.

Prediabetes

VALBIOTIS publishes the first prediabetes market data.

Read the press release
S c r o l l

Products

.01

Pipeline

4 products in clinical development

Learn more

.02

VALEDIA® – Prediabetes

Prediabetes
• Reduction of the risk of type 2 diabetes
• Phase IIa clinical study ongoing

Learn more

.03

LpD64

Overweight and /or obesity
• Modulation of intestinal microbiota
• Clinical Phase I/II positive

Learn more

.04

VAL-070

Mild to moderate hypercholesterolemia
• Reduction of blood LDL-cholesterol
• Clinical Phase I/II positive

Learn more

.05

VALEDIA® – Non alcoholic fatty liver

Non-alcoholic fatty liver (NAFL)
• Reduction of NAFL, risk factor for NASH
• Clinical Phase I/II positive

Learn more

Key figures

Patent families filed

4
All exploitation rights obtained

Employees

> 35
75% in R&D

Listed on the Stock Exchange

2017
Euronext Growth

Our last posts

15.03.2019

Les Echos : Maladie de civilisation recherche prévention efficiente

En savoir plus
05.02.2019

Biotech Day, SFAF, Paris

En savoir plus
22.01.2019

Biomed Event, Invest Securities, Paris

En savoir plus
07.01.2019

J.P. Morgan Healthcare Conference

En savoir plus
Voir tous

VALBIOTIS© listed on the Stock Exchange

Follow us!

19.03.2019 - 16:43

VALBIOTIS strengthens its Supervisory Board with the appointment of Agnes Tixier: https://bit.ly/2pIWrBx

11.03.2019 - 08:22

VALBIOTIS publishes the first prediabetes market data 🇺🇸🇨🇦🇩🇪🇪🇸🇫🇷🇮🇹🇬🇧 AEC Partners: https://bit.ly/2pIWrBx

08.03.2019 - 16:43

VALBIOTIS publishes its 2018 annual report and announces its results: https://bit.ly/2pIWrBx

07.03.2019 - 09:12

https://lnkd.in/gDuwfUx Merci Les Echos pour cette prise de position. VALBIOTIS, un acteur engagé dans la prévention du diabète de type 2.

26.02.2019 - 15:57

Rejoignez l'équipe VALBIOTIS pour un stage Assurance Qualité d'une durée de 3 mois. Pour postuler : https://bit.ly/2QXK407

11.02.2019 - 16:41

VALBIOTIS obtains the European patent for VALEDIA®: https://bit.ly/2pIWrBx

See more